Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy

Frontiers in Pharmacology

Pharmacology

Longbin Zhang¹  Zufeng Guo¹  Wei Zhang¹  Kunling Song¹  Guobing Yin²  Xing Wang³ 

[1] Center for Novel Target and Therapeutic Intervention, Institute of Life Sciences, Chongqing Medical University, Chongqing, China;Department of Breast and Thyroid Surgery, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China;Department of Breast and Thyroid Surgery, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China;Center for Novel Target and Therapeutic Intervention, Institute of Life Sciences, Chongqing Medical University, Chongqing, China;

关键词: PTGR1;    tumor metabolism;    eicosanoid pathways;    cancer therapeutics;    inhibitor;   

DOI  :  10.3389/fphar.2023.1220144

 received in 2023-05-10, accepted in 2023-05-18,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Wang, Yin, Zhang, Song, Zhang and Guo.